Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Beta-1,3-glucuronyltransferase 3 pseudogene 1 (B3GAT3P1)** is a pseudogene and does not encode a functional protein or enzyme. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they arise from gene duplication or retrotransposition and typically lack the regulatory elements necessary for gene expression or have acquired disabling mutations. Thus, B3GAT3P1 has no known biological function, disease association, or role as a drug target or biomarker[3].\n\nSummary of evaluation:\n\n- **B3GAT3P1 (Beta-1,3-glucuronyltransferase 3 pseudogene 1)** is not an active gene and does not code for a functional protein. By definition, pseudogenes are not considered therapeutic targets and have no known molecular function or role in disease pathways. There is no evidence linking this pseudogene to any interacting drugs, mechanisms of action, disease associations, or biomarkers. The requested abbreviation (PSIGLCAT-I) is a synonym, but the molecule is not a drug-target or therapeutic receptor, enzyme, or transporter[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-1,3-glucuronyltransferase 3 pseudogene 1 (B3GAT3P1).